Prime Medicine【PRME】株式ニュース

名称	銘柄コード	市場	種別
Prime Medicine Inc	PRME	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	0.00	0.00%	6.50	17:36:11

始値	安値	高値	終値	前日終値
				6.50

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/22	05:06	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
2024/5/22	05:03	EDGAR2	Form 8-K - Current report
2024/5/13	21:00	GLOBE	Prime Medicine to Present at H.C. Wainwright 2nd Annual..
2024/5/10	21:22	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/10	21:05	EDGAR2	Form 8-K - Current report
2024/5/10	21:00	GLOBE	Prime Medicine Reports First Quarter 2024 Financial Results..
2024/5/08	21:00	GLOBE	Prime Medicine Presents Preclinical Data Demonstrating..
2024/5/01	21:00	GLOBE	Prime Medicine to Participate in the 27th Annual Milken..
2024/4/29	20:00	GLOBE	Prime Medicine Announces FDA Clearance of Investigational..
2024/4/23	21:00	GLOBE	Prime Medicine to Present Preclinical Data Demonstrating..
2024/3/01	22:09	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
2024/3/01	22:04	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/01	22:01	EDGAR2	Form 8-K - Current report
2024/3/01	22:00	GLOBE	Prime Medicine Reports Full Year 2023 Financial Results and..
2024/2/28	22:00	GLOBE	Prime Medicine to Participate in Upcoming Investor..
2024/2/24	07:03	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/24	07:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/23	11:31	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
2024/2/21	07:38	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/21	06:01	GLOBE	Prime Medicine Announces Closing of Upsized Public Offering..
2024/2/16	20:23	EDGAR2	Form 8-K - Current report
2024/2/16	20:17	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/15	13:50	GLOBE	Prime Medicine Announces Pricing of Upsized Public Offering
2024/2/15	11:57	EDGAR2	Form FWP - Filing under Securities Act Rules 163/433 of free..
2024/2/15	07:27	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/15	06:12	EDGAR2	Form 8-K - Current report
2024/2/15	06:05	GLOBE	Prime Medicine Announces Proposed Public Offering of Common..
2024/1/25	22:00	GLOBE	Prime Medicine Receives Up to $15 Million from Cystic..
2024/1/08	22:01	EDGAR2	Form 8-K - Current report
2024/1/06	07:03	EDGAR2	Form 8-K - Current report
2024/1/05	22:15	EDGAR2	Form 8-K - Current report
2024/1/05	22:00	GLOBE	Prime Medicine Appoints Allan Reine, M.D., as Chief..
2024/1/02	22:00	GLOBE	Prime Medicine to Present at 42nd Annual J.P. Morgan..
2023/11/14	14:15	EDGAR2	Form EFFECT - Notice of Effectiveness
2023/11/08	22:00	GLOBE	Prime Medicine to Present at Upcoming Investor Conferences
2023/11/04	06:23	EDGAR2	Form S-3 - Registration statement under Securities Act of..
2023/11/04	06:09	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/04	05:06	EDGAR2	Form 8-K - Current report
2023/11/04	05:01	GLOBE	Prime Medicine Reports Third Quarter 2023 Financial Results..
2023/10/27	19:00	GLOBE	Prime Medicine Presents First-ever Prime Editing Data in..
2023/10/24	20:30	GLOBE	Prime Medicine Presents First In Vivo Proof-of-Concept Prime..
2023/10/17	21:00	GLOBE	Prime Medicine to Highlight Positive Preclinical..
2023/9/19	21:00	GLOBE	Prime Medicine to Present at Upcoming Investor Conferences
2023/8/31	21:00	GLOBE	Prime Medicine to Present at Upcoming Investor Conferences
2023/8/08	05:09	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/08	05:04	EDGAR2	Form 8-K - Current report
2023/8/08	05:01	GLOBE	Prime Medicine Reports Second Quarter 2023 Financial Results..
2023/6/22	21:00	GLOBE	Prime Medicine and Cimeio Therapeutics Announce Research..
2023/5/31	21:00	GLOBE	Prime Medicine to Present at Investor Conferences in June